Nanotechnology : London

Faraday Discussion 143: Soft Nanotechnology

Admin — Fri, 27 Jun 2008 10:50:56 +0100

Short description

Faraday Discussion 143 will incorporate aspects of structuring soft-materials at the nanoscale and the incorporation of such materials into actual devices.

Long description

Faraday Discussion 143 will incorporate aspects of structuring soft-materials at the nanoscale and the incorporation of such materials into actual devices.

Biological cells are the ultimate example of 'soft machines', which rely on the operation of complex molecular machines made of organic matter. It is clear that man-made attempts to emulate biological systems are nowhere near the same level of complexity.

Soft nanotechnology aims to build on our knowledge of biological systems, by implementing self-assembly and 'wet chemistry' into electronic devices, actuators, fluidics, etc. Understanding, predicting and utilising the rules of self-assembly (be it at solid liquid interfaces, in solution, or in block copolymers) and interface the resulting complex structures in well-defined 2D and 3D arrangements.

The control of nanoscale features of polymers in two and three dimensions impacts on device physics as much as on cell adhesion and cell differentiation. As we are approaching the limits of Moore's law the demand for more advanced and sophisticated polymers suitable for patterning at the nanoscale as much as the need for new materials compatible with alternative patterning can only be satisfied if we understand the fundamental nature of self-assembly and self-organization of organic materials in this context.

Themes

Fundamental questions that will be addressed during the discussion are:

* What are the new effects when patterning soft materials at the nanoscale? (i.e. where do 'materials' break up into 'molecules', how do physical/mechanical properties change with size).
* How can these effects be understood and exploited?
* Is it possible to go one step further and predict yet unencountered behaviour?
* What are the limitations in feature shape, sizes, complexity and function that are accessible via direct patterning and self-assembly?
* How much progress is being made into fabricating/assembling devices based on such structured polymers. Can we ever rival silicon devices or cellular function?

Scientific Committee

Professor Wilhelm Huck (University of Cambridge, UK) (Co-chair)

Dr Joachim Steinke (Imperial College London, UK) (Co-chair)

Professor Ullrich Steiner (University of Cambridge, UK)

Professor Tony Cass (Imperial College London, UK)

Professor Ulrich Wiesner (Cornell University, USA)

Professor Dr David Reinhoudt (University of Twente, The Netherlands)

Event precise location and contact information

15 - 17 June 2009
The Royal Society, London, UK
http://www.rsc.org/ConferencesAndEvents/RSCConferences/FD143/index.asp

Web site Url link

Web site Url text

Nanodrugs 2008: 1st International Conference on NanoDrugs and Clinical NanoTechnology

jwaslif — Wed, 04 Jun 2008 16:54:06 +0100

Short description

http://www.spectraintelligence.com/nanodrugs.htm

Arrowhead–Spectra’s 1st International Conference on Nanodrugs and Clinical Nanotechnology provides an unmissable forum to learn the challenges and advances of pioneers in nanodrug development and the nanotechnologies applied to medical therapies. Case studies of pipelines, progress and clinical efficacy, and challenges of bioengineering and manufacturing will be the main themes of the conference.

Long description

Nanotechnology has the potential to revolutionize medical treatments and medical practice. With hundreds of nanodrugs in development globally, the opportunities for clinical and market successes are apparent. Nanodrugs are at the forefront of bioengineering for diseases such as cancer, cardiovascular disease, and age-related conditions and represent the next generation of medical therapies that will impact worldwide markets, healthcare, and industry.

WHY ATTEND:
* Learn the latest developments in nanodrug development and clinical nanotechnology;
* Better understand the trends of nanodrug development;
* Learn from experts on the challenges and the solutions to bioengineering and manufacturing;
* Determine the efficacy of clinical stage nanodrug products;
* Establish the next generation market leaders in cancer and other therapy areas;
* Network with leaders from nanotechnology, pharma-biotech and healthcare industries

Event precise location and contact information

London, United Kingdom
Contact: Tim Atkinson, Arrowhead-Spectra Conferences
44 (0) 208 671 7726

Web site Url link

http://www.spectraintelligence.com/nanodrugs.htm

Web site Url text

‘Risk Management for NanoBusinesses’

Admin — Thu, 01 May 2008 15:00:05 +0100

Short description

Bringing Nanotechnology Products to Market: how to engender public confidence and exceed the requirements of regulators

Long description

The responsible development of any new technology requires that risks to health and the general environment associated with its development, production, use and disposal are addressed using sound scientific information and past experience. The difficulty with nanotechnology is that novel hazards and risks may be presented and this information may therefore be incomplete.

The public’s fear of ‘grey goo’ has been well-documented by the media. But negative public perceptions and a lack of consumer confidence can only fail to support a nano-industry in the UK. Moreover, the possibility of a potentially inappropriate regulatory framework could be serious barriers for UK companies in adopting nanotechnology, and could decelerate UK competitiveness.
In recent parliamentary discussions Ian Pearson MP highlighted current UK efforts to regulate nanotechnology health and safety and stressed to the house the Government's commitment to understanding any potential risks of nanotechnologies and to managing them within a proportionate regulatory framework.

Clearly, there also needs to be a bottom-up approach to risk management, and it is therefore vital that managers in organisations producing nanomaterials embrace a professional approach to this in order to increase public confidence, and also demonstrate to the regulatory bodies that all aspects of risk vs benefits are being properly assessed. Not only is this necessary to protect workers involved in production and use of these materials, the public and the ecosystem, but also it also helps inform the public debate about the development of these new, potentially beneficial, materials.

Consumers and producers are not the only parties pausing for thought in the nano-debate. Bringing nano-based products to the market raises questions for insurers. Limited precedence and a rapidly changing level of knowledge means that the concomitant lack of data with which to understand and assess nano-risks is an ongoing problem for insurance companies.

To address these issues, the Institute of Nanotechnology is hosting a key meeting - ‘Risk Management for NanoBusinesses' - which will provide risk management techniques for individuals involved in nanotechnology research and development within companies, universities and facilities. The main areas of discussion include building consumer confidence, looking at the extent to which UK regulatory structures have been adapted to suit nanomaterials, and an overview of the NanoMark Certification System in Taiwan , which is designed to build consumers' acceptance of Nanoproducts.

Event precise location and contact information

7th May 2008, Royal Institute of British Architects, London

For more details: http://www.nano.org.uk/courses/NanoBusinessesrisk.pdf

or telephone Carrie Smith : +44 (0)141 303 8444, email: carrie.smith@nano.org.uk

Web site Url link

Web site Url text

NANOTECHNOLOGY - TOWARDS REDUCING ANIMAL TESTING

Admin — Thu, 01 May 2008 14:54:55 +0100

Short description

Animal testing is costly and there is a great deal of research on finding viable and effective alternatives (new methods that refine existing tests by minimizing animal distress

Long description

Animal testing is costly and there is a great deal of research on finding viable and effective alternatives (new methods that refine existing tests by minimizing animal distress, reducing animal usage, or replacing whole animal tests). Despite large reductions in animal testing since the early 1980s due to improved in vitro methods, levels remain high (over 3 million procedures in 2006) and results cannot always be extrapolated to humans.

The application of nanotechnology is currently revolutionizing medicine and this two-day conference, the first of its kind in Europe, will examine the role nanotechnology could also play in improving or refining the development of alternatives to animal testing whilst maintaining safety. Themes will include:

* a review of some of the most promising human cell-based in vitro models
* novel lab-on-a-chip and bioreactor systems for screening, toxicology and targeting studies
* surface modification at the nanoscale to improve biosensors and in vitro test systems
* potential new strategies for applying nanotechnology to alternatives
* the role of the European Centre for the Validation of Alternative Methods (ECVAM)

The conference will be of particular interest to those involved in:

* pharmaceutical, medical device and cosmetic development and testing
* environmental and food testing
* regulation
* organizations interested in the development of animal alternatives.

Event precise location and contact information

Details....
http://www.nano.org.uk/conferences/alt_Animals/prog.htm

Web site Url link

Web site Url text

Nanotechnology: Towards Reducing Animal Testing - London

Admin — Mon, 07 Apr 2008 14:10:51 +0100

Short description

Applying understanding at the nanoscale to improving achievement of the ‘three Rs’
...replacement, refinement and reduction

Long description

This Conference, the first of its kind in Europe, will examine how nanotechnology could contribute to alternatives to animal testing and also to realisation of the “3Rs”, whilst maintaining the necessary high levels of safety in the pharmaceutical, medical device, chemical, cosmetic and environmental industries.

At this event, leading international experts will
review some of the most promising new, human cell-based in vitro models
describe novel lab-on-a-chip and bioreactor systems for screening, and for toxicological and targeting studies
examine how understanding of the behaviour of materials at the nanoscale can be used to improve biosensors and diagnostic systems
consider new paradigms for applying alternatives incorporating nanotechnology

Speakers include:
Fanqin Frank Chen (Lawrence Berkeley National Laboratory, USA); Antonio Garcia (Arizona State University, USA); Béatrice Schaack (CEA Grenoble, France); Thomas Peter (Fraunhofer IGB, Stuttgart, Germany); Peter Ertl (Austrian Research Centres, Vienna, Austria); Anna Price (European Commission Joint Research Centre, ISPRA, Italy); John Haycock (Kroto Research Institute, Sheffield, UK) and other experts from leading research, animal welfare and alternatives organisations.

Visit www.nano.org.uk/conferences/alt_Animals/prog.htm for further information and registration details.

Event precise location and contact information

28/29 May 2008

Web site Url link

Web site Url text

Short Course: Risk Management for NanoBusinesses - London

Admin — Mon, 07 Apr 2008 14:08:55 +0100

Short description

Bringing Nanotechnology Products to Market - how to engender public confidence and exceed the requirements of regulators.

Long description

Negative public perceptions and the possibility of a potentially inappropriate regulatory framework could be serious barriers for UK companies in adopting nanotechnology, and may act as a brake on UK competivity.

It is vital that managers in organisations producing nanomaterials embrace a professional approach to risk management as means of increasing public confidence, and also demonstrating to the regulatory bodies that all aspects of risk vs benefits are being properly assessed. This half-day meeting will provide an introduction to risk management techniques for individuals involved in nanotechnology research and development within companies, universities and facilities.

Invited Speakers:

Dr Gwo-Sheng Peng, Industrial Technology Research Institute in Taiwan will discuss the NanoMark certification system established in Taiwan to further encourage domestic manufacturers to develop nanoproducts and upgrade consumers' acceptance of nanoproducts.

Professor Robert G. Lee, Cardiff University ESRC Centre for Business Relationships, Accountability, Sustainability and Society Cardiff University will present on nanotechnology regulation in the UK, and whether regulatory structures for products are well adapted to suit nanomaterials, and the difficulties and uncertainties both in introducing products to the market, and thereafter in their life cycle.

Richard Moore, Manager, Nanomedicine and Lifesciences, Institute of Nanotechnology has spent 20 years on risk management for medical device companies and will discuss the particular challenges for nano businesses and other nano research and development organizations.

Matthew Clark, Science & Technology Divisional Director, La Playa Insurance will describe insurance issues in bringing nano based products to the market.

Visit www.euronanotrade.com/news/CourseREgMay08.pdf to register.

Event precise location and contact information

7th May 2008

Web site Url link

Web site Url text

What is Nanomedicine?

Carrie Smith — Thu, 06 Mar 2008 18:22:58 +0000

Short description

This one-day introductory course, delivered in partnership with Cranfield University, is aimed at clinicians, researchers, industry professionals and others who require a broad overview of the new field of nanomedicine and its amazing implications for 21st Century medicine.

Long description

Event precise location and contact information

The Linnean Society of London
Burlington House
Piccadilly
London
W1J 0BF
United Kingdom

Web site Url link

http://www.nano.org.uk/events/ionevents.htm#courseLondon

Web site Url text

Institute of Nanotechnology

3rd International Conference on Nanotechnology and Smart Textiles for Industry, Healthcare and Fashion’

Admin — Thu, 07 Feb 2008 01:03:26 +0000

Short description

The latest innovations are being used to bring imaginative, exciting and novel properties to textiles for fashion and industry.

Long description

The latest innovations are being used to bring imaginative, exciting and novel properties to textiles for fashion and industry. These range from scent-embedded textiles, stay-clean textiles, textiles with displays and textiles that can change colour, to lightweight textiles that are so strong they can withstand the impact of a bullet. Many new textiles are also being developed for health, promoting faster healing and enhancing health and well-being.

The aim of the 3rd International conference on Nanotechnology and Smart Textiles for Industry and Fashion is to provide an international platform where a diverse community of professionals from industry, academia and fashion can come together to share information, research findings and practical experiences. The conference will provide introductory and in-depth information on technology in a large spectrum of already realized or just being developed textile applications, and showcase current products.

Event precise location and contact information

For further information contact Gemma McCulloch, gemma.mcculloch@nano.org.uk

Web site Url link

http://www.nano.org.uk/events/ionevents.htm

Web site Url text

Piribo

Admin — Wed, 06 Feb 2008 17:09:30 +0000

Ticker Id

Web url

www.piribo.com

Contact Email

service@piribo.com

Short description

Street address

169 Tower Bridge Road

Zip or postal code

SE1 3LJ

Telephone

+44 (0) 20 7060 7474

Fax

+44 (0) 70 9281 2161

Foundation date

Ceo, president

Number of employees

Long description

The source for information products for the global biotechnology, healthcare and pharmaceutical industries.

Use Piribo to browse thousands of business information studies, market reports and books. Find the research you need in your work.

Why Piribo?

Piribo - Online Business Intelligence for the BioPharma Industry.
We have relationships with many of the leading publishers in the fields of biotechnology and pharmaceuticals so you can easily view and buy titles in one place.

Piribo carries the following types of publications;

* Pharmaceutical market research reports
* Pharmaceutical industry studies
* Biotech sector information
* Biotechnology industry intelligence
* Biopharma related books

The Piribo Advantage
Specialism: Piribo's focus is your focus

* By only carrying products that cover the biotechnology and pharmaceutical industry sector we can offer the best range of titles.
* Our research specialists can advise you.
* View and select from thousands of pharmaceutical industry books and reports.

Speed: Piribo saves you time

* By listing so many reports and books in one place you do not have to spend ages surfing the web looking for that elusive title.
* Many reports can be accessed through your briefcase in PDF format allowing you to get to the information you need immediately.

Service: Piribo has humans here to help

* Piribo may be an internet site but it is staffed by humans. Call us or email if you have any queries.
* We can help you find the information you need in your business. Feel free to ask.

Additional Commentaries and remarks

Patents

Nature.com

Admin — Tue, 05 Feb 2008 18:02:14 +0000

Ticker Id

Web url

www.nature.com

Contact Email

Short description

Street address

4 Crinan Street

Zip or postal code

N19XW

Telephone

+44 (0)20 7833 4000

Fax

+44 (0)20 7843 4640

Foundation date

Ceo, president

Number of employees

Long description

Nature is the world's foremost weekly scientific journal and is the flagship journal for Nature Publishing Group (NPG). Launched in 1869, its original mission statement still leads the Group as we develop publications, explore opportunities arising from new technology and serve a growing audience of readers:

NPG publishes journals and online databases across the life, physical and applied sciences and, most recently, clinical medicine. Content encompasses daily news from award-winning journalists, expert opinion and practical methodology, and more high impact research and reviews than any science publisher. Over 30 journals are published in association with prestigious academic societies. For information on NPG publications and their impact, go to the catalog.

NPG has an enviable reputation for innovation, developing timely and award-winning solutions to scientists' information needs. The file sharing resource, Connotea, was awarded the ALPSP Award for Publishing Innovation. The Nature Network series is connecting scientists at a global and local level. The success of the weekly Nature podcast has led to the construction of NPG's own in-house podcast studio to accommodate our multi-media ambitions. Go to NPG's Launchpad for news of our latest innovations.

For today's scientists and non-scientists, nature.com serves the NPG mission better than the original editors could have ever conceived. Nature.com is one of the most popular scholarly websites on the internet, serving almost 12 million visitors a month. Authors, editors and readers interact through letters, blogs, file-sharing and social networks. Site licenses are the most popular means of access with institutional accounts managed on a single-site, state-wide, national and international level.

NPG is an important member of the global community of science and contributes to HINARI and AGORA.

NPG now employs over 700 individuals and offers a flexible, dynamic working environment. Staff are encouraged to be creative and work independently, with access to thought provoking web seminars from leading thinkers and entrepreneurs. NPG's global presence and variety of publishing programs offer exciting career development opportunities; in addition to London and New York, offices have been opened in Oxford, Boston, Philadelphia, San Francisco, Hong Kong, Buenos Aires and Gurgaon. Read our history for a timeline of NPG and the scientific events which have helped shape the direction of the business.

NPG is a subsidiary of Macmillan Publishers Ltd, a global publishing group founded in the United Kingdom in 1843. Macmillan is itself owned by German-based, family run company Verlagsgruppe Georg von Holtzbrinck GmbH.

Additional Commentaries and remarks

Patents

Nanotechnology - TOWARDS REDUCING ANIMAL TESTING

Admin — Fri, 01 Feb 2008 00:34:30 +0000

Short description

The Conference will be of particular interest to those in the chemical, pharmaceutical, food and other industry sectors

Long description

The Conference will be of particular interest to those in the chemical, pharmaceutical, food and other industry sectors who are obliged to work towards alternative testing methods, as well as to regulators, test laboratories and organizations working towards the reduction of animal experiments and promotion of the “3Rs” principles.

Event precise location and contact information

Download ..... Details and registration
http://www.nano.org.uk/conferences/alt_Animals/animalflyer_whiteback.pdf

Kate Ryan on + 44 (0) 1684 893 712 or email reservations@venuesolutions.com
Please request preferential rates on our attached accommodation form.

Web site Url link

http://www.nano.org.uk/conferences/alt_Animals/prog.htm

Web site Url text

Nanotechnology and fashion

JohnT — Thu, 17 Jan 2008 17:18:50 +0000

Short description

A conference on micro and nanotechnologies for fashion and textiles

Long description

A conference on micro and nanotechnologies for fashion and textiles will take place in London, UK, on 24 January.

The event will highlight how small technologies are transforming fashion and further enabling the fashion and textile industries to deliver new products and designs.

Experts from nanotechnology and fashion will come together for the day, which is organised jointly by Cientifica and the London College of Fashion.

Event precise location and contact information

For further information, please visit:
http://www.cientifica.eu/fashion

Category: Events
Data Source Provider: Cientifica
Document Reference: Based on an event announcement
Subject Index: Materials Technology; Nanotechnology and Nanosciences

Web site Url link

Web site Url text

Skyepharma

vinay1210 — Tue, 15 Jan 2008 11:39:18 +0000

Ticker Id

Web url

http://www.skyepharma.com/

Contact Email

ljones@skyepharma.co.uk

Short description

Street address

105 Piccadilly

Zip or postal code

Telephone

(44) 207 491 1777

Fax

(44) 207 491 3338

Foundation date

Ceo, president

Number of employees

Long description

As world leaders in drug delivery technology, SkyePharma provides the pharmaceutical industry with the tools to develop and commercialise new pharmaceutical products and patients with more effective and user-friendly treatments. In addition, SkyePharma has used its delivery technologies to successfully develop a number of new proprietary products from its own, internally-funded portfolio. Typically, these products are licensed to third parties for commercialisation on completion of clinical development, although, in some cases, products have been licensed once approval for marketing has been obtained. By investing its own resources, SkyePharma creates additional value in the resulting products thereby achieving higher out-licensing fees and a greater share of the commercial rewards.

Additional Commentaries and remarks

Patents

Cientifica

vinay1210 — Mon, 14 Jan 2008 07:29:59 +0000

Ticker Id

Web url

http://www.cientifica.eu/

Contact Email

Short description

Street address

7 Devonshire Square

Zip or postal code

Telephone

Fax

Foundation date

Ceo, president

Number of employees

Long description

MICRO AND NANOTECHNOLOGIES FOR FASHION AND TEXTILES (MNFT) is a new event that brings its focus beyond the impact of small technologies on textiles, but how these technologies are changing fashion.

With speakers ranging from the largest textile associations, fashion designers and retailers and some of the most influential technology companies, MFNT will examine how micro and nanotechnologies have changed how textiles are made, but will also demonstrate how this new paradigm is changing the way designers approach fashion.

Additional Commentaries and remarks

Patents

nanotechweb

vinay1210 — Mon, 14 Jan 2008 06:02:45 +0000

Ticker Id

Web url

nanotechweb

Contact Email

custserv@iop.org

Short description

Street address

IOP Publishing, Dirac House

Zip or postal code

Telephone

+44 117 929 7481

Fax

+44 117 930 1178

Foundation date

Ceo, president

Number of employees

Long description

Founded in 2002, nanotechweb.org was the first portal designed to serve the information needs of the world-wide nanotechnology community. Now with more than 34,000 unique visitors each month, channelized content and weekly e-mail newswires to 23,000 opt-in subscribers, nanotechweb.org is a key information source for the nanotechnology community.

Reach 34,000 unique visitors per month, plus 23,000 subscribers to our e-mail newswire.

Additional Commentaries and remarks

Patents

'Micro and Nano Technologies for Food - a healthy and safe option?'

JohnT — Fri, 11 Jan 2008 01:21:11 +0000

Short description

The 2008 Albert Franks Memorial Lecture
The Royal Society, London

Long description

The 2008 Albert Franks Memorial Lecture will be given by Dr Frans Kampers, currently director of BioNT, the Wageningen biotechnology centre for food and health innovation.

Frans Kampers is one of Europe’s most knowledgeable and charismatic presenters on the topic of novel foods, and no stranger to controversy. His wide-ranging lecture will cover - the benefits and risks of nanotechnology as applied to foods and healthfoods; the opportunities nanotechnology offers for improved safety; and how nanoadditives are providing enhanced nutritional and health benefits. He will also discuss the responsibility of food manufacturers to demonstrate that new applications are safe!

Event precise location and contact information

Web site Url link

Web site Url text

Albert Franks Memorial Lecture 2008

JohnT — Wed, 09 Jan 2008 06:16:00 +0000

Short description

Nanotechnology and Food - did you know that:

Long description

Nanotechnology and Food - did you know that:
The nanofood market reached 5.3 bn. US dollars in 2005 and is expected to reach 20.4 bn. US dollars in 2015?
Milk is a nanoscale colloid and that nanotechnology could change the flow properties of ketchup?
Some nanomaterials have received the NSF registration required for use in food/beverage manufacturing facilities, denoting that they are safe for incidental contact with food?

Want to learn more?
Dr Frans Kampers, an expert on bio and nano technology as applied to nutrition, and one of Europe's most knowledgeable and charismatic presenters on the topic of novel foods, will discuss a variety of issues related to nanotechnology and food in his upcoming lecture, including topics such as:
Nanotechnologies for enhancing the nutritional value of food.
Can food be made better tasting, healthier and longer lasting from the application of nanotechnology?
What are the benefits and risks involved with nanotechnology and food?
How can industry demonstrate show that nano applications are safe?

This lecture is free to attend and will commence at 18.30 hrs, preceded by a drinks reception from 17.45 hrs.

Event precise location and contact information

To attend please register at http://www.nano.org.uk/events/franks_reg.htm or call Carrie Smith on 01786 447 520.

lbert Franks Memorial Lecture 2008

17 January 2008: The Royal Society, London

Web site Url link

Web site Url text

Nanotechnology: A Contributor to Reducing Animal Experiments?

Benj — Tue, 07 Aug 2007 14:50:59 +0100

Short description

Due to the limitations and costs of animal experimentation there is a great deal of research being carried out on finding viable and effective alternatives. This conference will highlight some of the potential applications in nanotechnology in reducing animal experiments whilst maintaining safety for patients and consumers.

Long description

Call for speaking and poster presentations. Please submit a short abstract (no more than 200 words) to Carrie Smith, carrie.smith@nano.org.uk by September 14th, 2007. Any requests received after this date will be subjected to availability.

To register your attendance please visit http://www.nano.org.uk/events/ionevents.htm

Event precise location and contact information

The Royal Society, London

Web site Url link

http://www.nano.org.uk/events/ionevents.htm

Web site Url text

http://www.nano.org.uk/events/ionevents.htm

Nanotechnology for Security and Crime Prevention

Benj — Tue, 07 Aug 2007 14:47:55 +0100

Short description

Building on the success of the previous conference this one day event will examine a wide spectrum of new scientific developments taking place in the fight against crime. The latest discoveries and advances will be discussed, from the latest research in nanotechnology and forensics to explosives detection that will revolutionise our security sector.

Long description

Call for speaking and poster presentations. Please submit a short abstract (no more than 200 words) to Carrie Smith, carrie.smith@nano.org.uk by August 31st, 2007. Any requests received after this date will be subjected to availability.

To register your attendance please visit http://www.nano.org.uk/events/ionevents.htm

Event precise location and contact information

The Royal Society, London

Web site Url link

http://www.nano.org.uk/events/ionevents.htm

Web site Url text

http://www.nano.org.uk/events/ionevents.htm

Investing in Medical Nanotechnologies II

Benj — Tue, 07 Aug 2007 14:45:44 +0100

Short description

Building on the success of 'Investing in Medical Nanotechnologies', this annual nanomedicine conference and exhibition will showcase state-of-the-art scientific developments in the healthcare applications of nanotechnology as well as opportunities for investment.

Long description

* Learn how nanotech drives new technology applications in medicine, from top industrial leaders.
* Hear about the best investing strategies and current activities at EU level.
* Find out about new technologies for medical applications.
* Participate in discussions with experts in the field.
* Meet exhibitors at the cutting edge of medical nanotechnology.

Showcasing nanomedical technologies including:
* Tissue engineering and regenerative medicine
* Drug discovery and delivery
* New technologies for implants and devices
* Novel nanosensors and diagnostic techniques
* Clinical applications of nanotechnology

Register now at http://www.nano.org.uk/events/ionevents.htm to take advantage of early bird rate! (Ends 30th September 2007)

Event precise location and contact information

Royal College of Surgeons, London

Web site Url link

http://www.nano.org.uk/events/ionevents.htm

Web site Url text

http://www.nano.org.uk/events/ionevents.htm